NEW YORK (GenomeWeb) – Siemens Healthineers announced today that it has reached a deal to acquire Fast Track Diagnostics. The acquisition adds more than 80 platform-agnostic assays and syndromic panels to the menu of tests for Siemens' Versant kPCR Molecular System.
The acquisition also includes a workforce of about 80 employees and sites in FTD’s home base of Luxembourg, as well as in Malta and India. FTD will continue to operate under the brand name Fast Track Diagnostics throughout the world, Siemens said in a statement.
Terms of the deal were not disclosed.